Racial differences in lens opacity incidence and progression: The salisbury eye evaluation (SEE) study

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 4, 2013, Pages 3010-3018

  Storey, Philip ^a   Munoz, Beatriz ^a   Friedman, David ^a   West, Sheila ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

African American; Cataract; Caucasian; Lens opacity; Longitudinal study; Population based study

Indexed keywords

AGE; AGED; ARTICLE; CATARACT; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RACE DIFFERENCE; RELIABILITY; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; ULTRAVIOLET RADIATION;

EID: 84876839468     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11412     Document Type: Article

References (53)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82:844-851.
2. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
3. Podgor MJ, Leske MC, Ederer F. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. Am J Epidemiol. 1983;118:206-212.
4. The Italian-American Cataract Study Group. Incidence and progression of cortical, nuclear, and posterior subcapsular cataracts. Am J Ophthalmol. 1994;118:623-631.
5. Klein BE, Klein R, Lee KE. Incidence of age-related cataract: the Beaver Dam Eye Study. Arch Ophthalmol. 1998;116:219-225.
6. Cedrone C, Culasso F, Cesareo M, et al. Prevalence and incidence of age-related cataract in a population sample from Priverno, Italy. Ophthalmic Epidemiol. 1999;6:95-103.
7. McCarty CA, Mukesh BN, Dimitrov PN, et al. Incidence and progression of cataract in the Melbourne Visual Impairment Project. Am J Ophthalmol. 2003;136:10-17.
8. Kanthan GL, Wang JJ, Rochtchina E, et al. Ten-year incidence of age-related cataract and cataract surgery in an older Australian population: the Blue Mountains Eye Study. Ophthalmology. 2008;115:808-814.
9. Leske MC, Wu SY, Nemesure B, et al. Incidence and progression of lens opacities in the Barbados Eye Studies. Ophthalmology. 2000;107:1267-1273.
10. Varma R, Richter GM, Torres M, et al. Four-year incidence and progression of lens opacities: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2010;149:728-734.
11. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults: the Salisbury Eye Evaluation project. Invest Ophthalmol Vis Sci. 1997;38:72-82.
12. West SK, Duncan DD, Munoz B, et al. Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation project. J Am Med Assoc. 1998;280:714-718.
13. Caulfield LE, West SK, Barron Y, et al. Anthropometric status and cataract: the Salisbury Eye Evaluation project. Am J Clin Nutr. 1999;69:237-242.
14. West SK, Rosenthal F, Newland HS, et al. Use of photographic techniques to grade nuclear cataracts. Invest Ophthalmol Vis Sci. 1988;29:73-77.
15. West SK, Munoz B, Wang F, et al. Measuring progression of lens opacities for longitudinal studies. Curr Eye Res. 1993;12: 123-132.
16. West SK, Munoz B, Schein OD, et al. Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) project. Am J Epidemiol. 1998;148:1033-1039.
17. Leske MC, Connell AM, Wu SY, et al. Prevalence of lens opacities in the Barbados Eye Study. Arch Ophthalmol. 1997; 115:105-111.
18. Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol. 1986;124:916-925.
19. Sperduto RD, Hiller R. The prevalence of nuclear, cortical, and posterior subcapsular lens opacities in a general population sample. Ophthalmology. 1984;91:815-818.
20. Adamsons I, Munoz B, Enger C, et al. Prevalence of lens opacities in surgical and general populations. Arch Ophthalmol. 1991;109:993-997.
21. Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population: the Beaver Dam Eye Study. Ophthalmology. 1992;99:546-552.
22. Cumming RG, Mitchell P, Smith W. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology. 2000;107:450-456.
23. Brown L, Rimm EB, Seddon JM, et al. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr. 1999;93:1128-1135.
24. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to agerelated maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. 2001;153:424-432.
25. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet. 2004;36: 1312-1318.
26. Hammond CJ, Snieder H, Spector TD, et al. Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins. N Engl J Med. 2000;342: 1786-1790.
27. Hammond CJ, Duncan DD, Snieder H, et al. The heritability of age-related cortical cataract: the Twin Eye Study. Invest Ophthalmol Vis Sci. 2001;42:601-605.
28. Bhagyalaxmi SG, Padma T, Reddy GB, et al. Association of G>A transition in exon-1 of alpha crystallin gene in age-related cataracts. Oman J Ophthalmol. 2010;3:7-12.
29. Litt M, Kramer P, LaMorticella DM, et al. Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet. 1998;7: 471-474.
30. Horwitz J. Alpha-crystallin. Exp Eye Res. 2003;76:145-153.
31. Datiles MB, Ansari RR, Suh KI, et al. Clinical detection of precataractous lens protein changes using dynamic light scatter. Arch Ophthalmol. 2008;126:1687-1693.
32. Andley UP. Effects of alpha-crystallin on lens cell function and cataract pathology. Curr Mol Med. 2009;9:887-892.
33. Graw J. Genetics of crystallins: cataract and beyond. Exp Eye Res. 2009;88:173-189.
34. Puk O, Ahmad N, Wagner S, et al. First mutation in the betaA2- crystallin encoding gene is associated with small lenses and age-related cataracts. Invest Ophthalmol Vis Sci. 2011;52: 2571-2576.
35. Litt M, Carrero-Valenzuela R, LaMorticella DM, et al. Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human beta-crystallin gene CRYBB2. Hum Mol Genet. 1997;6:665-668.
36. Vanita V, Singh JR, Singh D, et al. Novel mutation in the gamma-S crystallin gene causing autosomal dominant cataract. Mol Vis. 2009;15:476-481.
37. Nandrot E, Slingsby C, Basak A, et al. Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts. J Med Genet. 2003;40:262-267.
38. Leske MC, Chylack LT Jr, Wu SY, et al. Incidence and progression of nuclear opacities in the Longitudinal Study of Cataract. Ophthalmology. 1996;103:705-712.
39. McCarty CA, Mukesh BN, Fu CL, et al. The epidemiology of cataract in Australia. Am J Ophthalmol. 1999;128:446-465.
40. Freeman EE, Munoz B, Schein OD, et al. Incidence and progression of lens opacities: effect of hormone replacement therapy and reproductive factors. Epidemiology. 2004;15: 451-457.
41. Klein BE, Klein R, Lee KE. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the Beaver Dam Eye Study. Am J Ophthalmol. 2000;130:322-326.
42. West S, Munoz B, Schein OD, et al. Cigarette smoking and risk for progression of nuclear opacities. Arch Ophthalmol. 1995; 113:1377-1380.
43. Ye J, He J, Wang C, et al. Smoking and risk of age-related cataract: a meta-analysis. Invest Ophthalmol Vis Sci. 2012;53: 3885-3895.
44. Kelly SP, Thornton J, Edwards R, et al. Smoking and cataract: review of causal association. J Cataract Refract Surg. 2005;31: 2395-2404.
45. McCarty CA, Taylor HR. A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol. 2002;35:21-31.
46. Gallagher RP, Lee TK. Adverse effects of ultraviolet radiation: a brief review. Prog Biophys Mol Biol. 2006;92:119-131.
47. Richter GM, Torres M, Choudhury F, et al. Risk factors for cortical, nuclear, posterior subcapsular and mixed lens opacities: the Los Angeles Latino Eye Study. Ophthalmology. 2012;119:547-554.
48. McCarty CA, Mukesh BN, Fu CL, et al. The epidemiology of cataract in Australia. Am J Ophthalmol. 1999;128:446-465.
49. Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998; 126:782-790.
50. Rowe NG, Mitchell PG, Cumming RG, et al. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2000;7:103-114.
51. Hennis AH, Wu S, Nemesure B, et al. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Epidemiology. 2004;122:525-530.
52. Delcourt C, Cristol JP, Tessier F, et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Am J Epidemiol. 2000;151:497-504.
53. Leske MC, Wu SY, Nemesure B, et al. Risk factors for incident nuclear opacities. Ophthalmology. 2002;109:1303-1308.